Physician profile
Aubrey Rae Downey
NPI 1639759525
$10,872.46
in general payments reported to CMS, 2019-2025
66 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $804 · 2022: $2,375 · 2023: $2,354 · 2024: $3,515 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,494 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,493.52 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,333.93 | 2021-2025 | |
| Ucb, INC. | $639.85 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $472.14 | 2022-2025 | Tremfya, Erleada |
| Leo Pharma INC. | $421.11 | 2024-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $418.61 | 2024-2025 | Sotyktu |
| Dendreon Pharmaceuticals LLC | $404.74 | 2022-2023 | Provenge |
| Regeneron Healthcare Solutions, INC. | $394.42 | 2024-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $353.20 | 2024-2025 | |
| Lilly USA, LLC | $305.89 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Coloplast Corp | $301.77 | 2022-2023 | Speedicath, Titan |
| Antares Pharma, INC. | $288.39 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Novo Nordisk INC | $262.97 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $256.87 | 2024-2025 | |
| Astellas Pharma US INC | $197.79 | 2022-2023 | Myrbetriq, Xtandi |
| Paratek Pharmaceuticals, INC. | $194.84 | 2021-2022 |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrey Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.